e Multi-Modal Immune Pathogenesis of Atopic Eczema
Atopic eczema (AE) is one of the most common inflammatory diseases, often constituting a lifelong burden for afflicted individuals. Recent findings have provided new insights into the pathogenesis of AE,…
cell.com
Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?
Atopic dermatitis (AD) is a paradigmatic chronic…
jacionline.org
Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
jaad.org
Topical Tofacitinib Hits Marks in Atopic Dermatitis
Key clinical point: Topical tofacitinib, a Janus kinase…
mdedge.com
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Original Article from The New England Journal of Medicine — Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
nejm.org
Dupixent: Injection for Eczema Wins FDA Nod
Approved for patients not responding to or unable to use topical agents
medpagetoday.com